Compare City Retail Developments Tbk. (NIRO) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
City Retail Developments Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? City Retail Developments Tbk. trades at Rp177 (market cap 4.11T, 2.5M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: City Retail Developments Tbk. is far larger — about 39.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| NIRO | SCPI | |
|---|---|---|
Market Cap | 4.11T | 104.4B |
Volume | 2.5M | — |
Lot | 25K | — |
Turnover | 465.22M | — |
Average Price | 186.12 | — |
Value | 465.22M | — |
Indicative Equilibrium Price | 177 | — |
Indicative Equilibrium Volume | 52 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About City Retail Developments Tbk.
Nirvana Development, PT was established on 18 Dec 2003. The Company has been established for the first time under the name PT Artha Adipura Primary which is based in Jakarta.
Read more on NIRO →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
